Table 2.

Rheumatologists’ current approaches to and attitudes about inadequate response to TNFi therapies

	%	n
Percentage of patients believed by rheumatologist to respond adequately to an initial TNFi therapy
Less than 20%	0.8	2
21–39%	19.8	49
40–59%	51.2	127
60% or more	28.2	70
The percent of rheumatologists who are concerned or very concerned about five issues related to inadequate response to TNFi therapies
Non-response increasing time to low disease activity state	73.0	181
Patients paying for drugs not getting them to targets	71.0	176
Difficulty predicting which patients will be non-responders	67.7	168
Difficulty getting other drugs approved by payers/plans	65.7	163
Non-responders having reduced patient satisfaction	64.1	159
Interest in a test to predict inadequate response to TNFi therapies
Not at all interested	1.2	3
Slightly interested	2.0	5
Moderately interested	11.3	28
Very interested	41.5	103
Extremely interested	44.0	109